MBX Biosciences, Inc. (MBX)

MBX Biosciences Statistics

Total Valuation

MBX Biosciences has a market cap or net worth of $1.33 billion. The enterprise value is $957.18 million.

Market Cap	1.33B
Enterprise Value	957.18M

Important Dates

The last earnings date was Thursday, March 12, 2026, before market open.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

MBX Biosciences has 47.51 million shares outstanding. The number of shares has increased by 243.01% in one year.

Current Share Class	47.51M
Shares Outstanding	47.51M
Shares Change (YoY)	+243.01%
Shares Change (QoQ)	+31.19%
Owned by Insiders (%)	2.75%
Owned by Institutions (%)	65.51%
Float	28.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.41
P/TBV Ratio	3.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.62, with a Debt / Equity ratio of 0.00.

Current Ratio	24.62
Quick Ratio	24.25
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.76% and return on invested capital (ROIC) is -19.53%.

Return on Equity (ROE)	-27.76%
Return on Assets (ROA)	-18.75%
Return on Invested Capital (ROIC)	-19.53%
Return on Capital Employed (ROCE)	-26.53%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.38M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +198.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+198.19%
50-Day Moving Average	35.24
200-Day Moving Average	22.01
Relative Strength Index (RSI)	34.43
Average Volume (20 Days)	596,319

Short Selling Information

The latest short interest is 2.40 million, so 5.04% of the outstanding shares have been sold short.

Short Interest	2.40M
Short Previous Month	2.20M
Short % of Shares Out	5.04%
Short % of Float	8.34%
Short Ratio (days to cover)	3.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-98.06M
Pretax Income	-86.97M
Net Income	-86.97M
EBITDA	-97.81M
EBIT	-98.06M
Earnings Per Share (EPS)	-$2.38

Balance Sheet

The company has $373.71 million in cash and $596,000 in debt, with a net cash position of $373.11 million or $7.85 per share.

Cash & Cash Equivalents	373.71M
Total Debt	596,000
Net Cash	373.11M
Net Cash Per Share	$7.85
Equity (Book Value)	369.22M
Book Value Per Share	8.22
Working Capital	366.04M

Cash Flow

In the last 12 months, operating cash flow was -$79.95 million and capital expenditures -$1.93 million, giving a free cash flow of -$81.88 million.

Operating Cash Flow	-79.95M
Capital Expenditures	-1.93M
Free Cash Flow	-81.88M
FCF Per Share	-$1.72

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBX Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-243.01%
Shareholder Yield	-243.01%
Earnings Yield	-6.54%
FCF Yield	-6.15%

Analyst Forecast

The average price target for MBX Biosciences is $54.20, which is 93.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$54.20
Price Target Difference	93.57%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2